{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:26:13Z","timestamp":1778635573551,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10787-024-01601-0","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T08:13:38Z","timestamp":1732695218000},"page":"885-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating diclofenac\u2019s risks in COVID-19: strategies for mitigating adverse outcomes"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8186-2926","authenticated-orcid":false,"given":"Chia Siang","family":"Kow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-7026","authenticated-orcid":false,"given":"Dinesh Sangarran","family":"Ramachandram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-2215","authenticated-orcid":false,"given":"Syed Shahzad","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3754-1690","authenticated-orcid":false,"given":"Kaeshaelya","family":"Thiruchelvam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"1601_CR1","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.12998\/wjcc.v11.i10.2189","volume":"11","author":"M Helou","year":"2023","unstructured":"Helou M, Nasr J, El Osta N, Jabbour E, Husni R (2023) Liver manifestations in COVID-19 patients: a review article. World J Clin Cases 11:2189\u20132200","journal-title":"World J Clin Cases"},{"key":"1601_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101751","volume":"37","author":"SH Jung","year":"2020","unstructured":"Jung SH, Lee W, Park SH, Lee KY, Choi YJ, Choi S, Kang D, Kim S, Chang TS, Hong SS, Lee BH (2020) Diclofenac impairs autophagic flux via oxidative stress and lysosomal dysfunction: implications for hepatotoxicity. Redox Biol 37:101751","journal-title":"Redox Biol"},{"issue":"3","key":"1601_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10787-021-00810-1","volume":"29","author":"CS Kow","year":"2021","unstructured":"Kow CS, Hasan SS (2021a) The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology 29(3):641\u2013644","journal-title":"Inflammopharmacology"},{"key":"1601_CR4","doi-asserted-by":"publisher","DOI":"10.5920\/bjpharm.836","author":"CS Kow","year":"2021","unstructured":"Kow CS, Hasan S (2021b) Pharmacist-patient communication amid COVID-19 pandemic: a review of available options and potential impact. Brit J Pharm. https:\/\/doi.org\/10.5920\/bjpharm.836","journal-title":"Brit J Pharm"},{"key":"1601_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01568-y","author":"N Mallah","year":"2024","unstructured":"Mallah N, Visos-Varela I, Takkouche B, Bugar\u00edn-Gonz\u00e1lez R, Pi\u00f1eiro-Lamas M, Herdeiro T, Zapata-Cachafeiro M, Rodr\u00edguez-Fern\u00e1ndez A, Salgado-Barreira A, Figueiras A, COVIDrug Group (2024) The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-024-01568-y","journal-title":"Inflammopharmacology"},{"key":"1601_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3426","volume":"362","author":"M Schmidt","year":"2018","unstructured":"Schmidt M, S\u00f8rensen HT, Pedersen L (2018) Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ 362:k3426","journal-title":"BMJ"},{"key":"1601_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/v15020553","volume":"15","author":"MJA Silva","year":"2023","unstructured":"Silva MJA, Ribeiro LR, Gouveia MIM, Marcelino BDR, Santos CSD, Lima KVB, Lima LNGC (2023) Hyperinflammatory response in COVID-19: a systematic review. Viruses 15:553","journal-title":"Viruses"},{"key":"1601_CR8","doi-asserted-by":"publisher","first-page":"5253623","DOI":"10.1155\/2018\/5253623","volume":"2018","author":"P Sriuttha","year":"2018","unstructured":"Sriuttha P, Sirichanchuen B, Permsuwan U (2018x) Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials. Int J Hepatol. 2018:5253623","journal-title":"Int J Hepatol."},{"issue":"2","key":"1601_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/hematolrep15020024","volume":"15","author":"H Sutanto","year":"2023","unstructured":"Sutanto H, Soegiarto G (2023) Risk of thrombosis during and after a SARS-CoV-2 infection: pathogenesis, diagnostic approach, and management. Hematol Rep 15(2):225\u2013243","journal-title":"Hematol Rep"},{"key":"1601_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10557-021-07253-4","volume":"37","author":"PN Thai","year":"2023","unstructured":"Thai PN, Ren L, Xu W, Overton J, Timofeyev V, Nader CE, Haddad M, Yang J, Gomes AV, Hammock BD, Chiamvimonvat N, Sirish P (2023) Chronic diclofenac exposure increases mitochondrial oxidative stress, inflammatory mediators, and cardiac dysfunction. Cardiovasc Drugs Ther 37:25\u201337","journal-title":"Cardiovasc Drugs Ther"},{"key":"1601_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07611-y","author":"MS Ullah","year":"2024","unstructured":"Ullah MS, Khan MAU, Ullah MS (2024) New evidence on diclofenac: implications for cardiovascular safety. Cardiovasc Drugs Ther. https:\/\/doi.org\/10.1007\/s10557-024-07611-y. (Advance online publication)","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01601-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01601-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01601-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:31Z","timestamp":1740107191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01601-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1601"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01601-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}